QCG
Quadrant Capital Group Portfolio holdings
AUM
$2.78B
1-Year Return
19.13%
This Quarter Return
+1.14%
1 Year Return
+19.13%
3 Year Return
+73.37%
5 Year Return
+122.71%
10 Year Return
+247.64%
AUM
$1.45B
AUM Growth
+$13.2M
(+0.92%)
Cap. Flow
+$18.6M
Cap. Flow
% of AUM
1.28%
Top 10 Holdings %
Top 10 Hldgs %
37.99%
Holding
2,835
New
102
Increased
926
Reduced
1,027
Closed
102
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
$9.11M |
| 2 |
JPMorgan Ultra-Short Income ETF
JPST
|
$8.62M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
$4.26M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
$2.43M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
$2.11M |
Top Sells
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$2.93M |
| 2 |
Apple
AAPL
|
$1.79M |
| 3 |
Schwab US Broad Market ETF
SCHB
|
$1.47M |
| 4 |
Eli Lilly
LLY
|
$503K |
| 5 |
Johnson & Johnson
JNJ
|
$450K |
Sector Composition
| 1 | Technology | 16.86% |
| 2 | Financials | 8.6% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.93% |
| 5 | Consumer Staples | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Axogen
AXGN
$735M
| $1.88K | ﹤0.01% |
114
-83
| -42% | -$1.37K |
|
2502
Ambac
AMBC
$422M
| $1.86K | ﹤0.01% |
147
+46
| +46% | +$582 |
|
2503
Distribution Solutions Group
DSGR
$1.48B
| $1.86K | ﹤0.01% |
54
| – | – |
|
2504
PACS Group
PACS
$1.73B
| $1.84K | ﹤0.01% |
140
| – | – |
|
2505
Relay Therapeutics
RLAY
$710M
| $1.83K | ﹤0.01% |
445
+394
| +773% | +$1.62K |
|
2506
Pilgrim's Pride
PPC
$10.5B
| $1.82K | ﹤0.01% |
40
| – | – |
|
2507
Olaplex Holdings
OLPX
$994M
| $1.81K | ﹤0.01% |
1,044
-5,384
| -84% | -$9.32K |
|
2508
Rocket Lab Corporation Common Stock
RKLB
$22.1B
| $1.76K | ﹤0.01% |
69
+30
| +77% | +$764 |
|
2509
Hippo Holdings
HIPO
$832M
| $1.74K | ﹤0.01% |
+65
| New | +$1.74K |
|
2510
PureCycle Technologies
PCT
$2.41B
| $1.72K | ﹤0.01% |
168
| – | – |
|
2511
Johnson Outdoors
JOUT
$423M
| $1.72K | ﹤0.01% |
52
-973
| -95% | -$32.1K |
|
2512
NVE Corp
NVEC
$323M
| $1.71K | ﹤0.01% |
21
| – | – |
|
2513
Orion
OEC
$596M
| $1.71K | ﹤0.01% |
108
-282
| -72% | -$4.46K |
|
2514
Kforce
KFRC
$598M
| $1.7K | ﹤0.01% |
30
| – | – |
|
|
PARA
2515
DELISTED
Paramount Global Class B
PARA
| $1.7K | ﹤0.01% |
162
-1,088
| -87% | -$11.4K |
|
2516
Celldex Therapeutics
CLDX
$1.52B
| $1.69K | ﹤0.01% |
+67
| New | +$1.69K |
|
2517
Pathward Financial
CASH
$1.74B
| $1.69K | ﹤0.01% |
23
| – | – |
|
2518
ADT
ADT
$7.13B
| $1.68K | ﹤0.01% |
243
| – | – |
|
2519
Warby Parker
WRBY
$3.17B
| $1.67K | ﹤0.01% |
69
| – | – |
|
2520
ICF International
ICFI
$1.75B
| $1.67K | ﹤0.01% |
14
| – | – |
|
2521
First Majestic Silver
AG
$4.47B
| $1.65K | ﹤0.01% |
300
| – | – |
|
2522
Unisys
UIS
$277M
| $1.65K | ﹤0.01% |
260
| – | – |
|
2523
Quanterix
QTRX
$211M
| $1.63K | ﹤0.01% |
153
+43
| +39% | +$457 |
|
2524
Esperion Therapeutics
ESPR
$540M
| $1.62K | ﹤0.01% |
735
| – | – |
|
2525
Gannett
GCI
$629M
| $1.59K | ﹤0.01% |
315
| – | – |
|